There are suggestions that omicron could result in COVID-19 transitioning from a pandemic to an endemic situation
The U.S. HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) today announced it was distributing 225,590 monoclonal antibody treatments but no COVID-19 oral antivirals this week.
There are four mAbs Authorized but not Approved by the U.S. FDA to treat certain patients as of January 17, 2022.
The ASPR distribution list shows the total number of patient courses that have been distributed across the country.
Scientists in Poland may have discovered a gene that more than doubles the risk of severe COVID-19.
Researchers from the Medical University of Bialystok in Poland found that the gene is the fourth most important factor determining how a person suffers from COVID-19, after age, weight, and gender.
This gene is located on chromosome 3, one of the 23 pairs of chromosomes in humans, and is present in around 14% of the Polish population, compared to 8-9% in Europe, and 27% in India.
Age, underlying chronic illness, and symptom duration tied to severe outcomes
The NCCN Advisory Committee supports the strong preference for mRNA vaccines and offers guidance on the timing of vaccination
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 10 to 14, 2022. This …
Easing the rules would result in a 2 to 4 percent increase — 345,400 to 615,300 more pints of blood — in the nation’s annual blood supply
Among those who voted against Califf’s nomination were Democrats who expressed concerns about his links to pharmaceutical companies
Mandate was a crucial component of the White House plan to tackle the COVID-19 pandemic
JAK inhibitor baricitinib strongly recommended for the treatment of severe or critical COVID-19